Blood Glucose Monitoring System (Glucose Oxidase)

FDA 510(k) K113636 · Philosys Co., Ltd.

Substantially Equivalent

510(k) numberK113636

Submission

Device name
Blood Glucose Monitoring System (Glucose Oxidase)
Applicant
Philosys Co., Ltd.
New York, NY, US
Received
December 9, 2011
Decision date
March 8, 2013
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
CGA – Glucose Oxidase, Glucose
Device class
Class II (moderate risk)
Regulation
21 CFR 862.1345
Specialty
Clinical Chemistry

Other 510(k)s with product code CGA

510(k)DeviceApplicantDecision
K252488ABL90 FLEX PLUS SystemCGA · Traditional Radiometer Medicals Aps05/01/2026SE
K210933YSI 2900C Biochemistry AnalyzerCGA · Traditional Ysi, Inc.09/30/2024SE
K220328EasyStat 300CGA · Traditional Medica Corporation07/26/2024SE
K223179Cholestech LDX ™ SystemCGA · Dual Track Alere San Diego, Inc.09/20/2023SE
K223755i-STAT G cartridge with the i-STAT 1 SystemCGA · Traditional Abbott Point of Care, Inc.09/11/2023SE
K223710i-STAT CG8+ cartridge with the i-STAT 1 SystemCGA · Traditional Abbott Point of Care, Inc.07/28/2023SE
K223090GEM Premier ChemSTATCGA · Special Instrumentation Laboratory CO01/27/2023SE
K203549Nova Primary Glucose Analyzer SystemCGA · Traditional Nova Biomedical Corporation10/18/2022SE
K210958i-STAT CHEM8+ cartridge with the i-STAT 1 SystemCGA · Traditional Abbott Point of Care, Inc.08/13/2021SE
K200349Stat Profile Prime Plus Analyzer SystemCGA · Traditional Nova Biomedical Corporation03/13/2020SE

More from Nova Biomedical Corporation

510(k)DeviceDecision
K151658Gmate Origin Blood Glucose Monitoring SystemNBW · Traditional 12/01/2015SE
K150299Gmate SMART Blood Glucose Monitoring SystemNBW · Traditional 11/19/2015SE
K141656Gmate Mini Blood Glucose Monitoring System, Gmate Step Blood Glucose Monitoring SystemNBW · Traditional 10/02/2015SE
K131230Gmate Smart Blood Glucose Monitoring System, Gmate Smart ApplicationNBW · Traditional 08/04/2014SE

Questions and answers

When was Blood Glucose Monitoring System (Glucose Oxidase) cleared by the FDA?

Blood Glucose Monitoring System (Glucose Oxidase) (K113636) received a 510(k) decision of Substantially Equivalent on March 8, 2013, 455 days after the submission was received.

What is the product code of K113636?

The FDA product code is CGA – Glucose Oxidase, Glucose, a Class II (moderate risk) device regulated under 21 CFR 862.1345.